The Art & Science of Wellness
ISNES, Belgium, March 25, 2019 /PRNewswire/ — VolitionRx Limited (NYSE AMERICAN: VNRX) (“Volition”) today announced that its Executive Vice President, Investor Relations, Scott Powell, is scheduled to present at three…
SUZHOU, China, March 21, 2019 /PRNewswire/ — CStone Pharmaceuticals (“CStone”; HKEX: 2616) today announced that China’s National Medical Products Administration (NMPA) has approved the clinical trial application to begin a…
-Showing commitment to help promote the rapid implementation of rare diseases treatment in China BEIJING, March 24, 2019 /PRNewswire/ — Sanofi Chief Executive Officer Olivier Brandicourt expressed yesterday that he…
Two in the U.S., one in Taiwan attain the gold standard WASHINGTON, March 22, 2019 /PRNewswire/ — The Association for the Accreditation of Human Research Protection Programs today announced its…
SHANGHAI, March 22, 2019 /PRNewswire/ — Exyte, the global leader in the design, engineering and construction of high-tech facilities, plants and factories, showcases its Smart Fab design concept at Semicon…
-Ping An Good Doctor Utilize Advanced Technology to Achieve Health and Poverty Alleviation BEIJING, March 21, 2019 /PRNewswire/ — The ceremony of “Village Warming with Blossom — Funding Presentation Ceremony…
– Molsheim, France center supports pharmaceutical and biotechnology customers from pre-clinical through full-scale production in non-GMP environment – Hands-on customer access to Merck’s Life Science product portfolio and technical expertise…
New report from Clarivate Analytics identifies seven new drugs predicted to achieve annual sales of >$1 billion by 2023 Game-changing therapies addressing immune-related and genetic disorders target under-served patient populations…
BEIJING, March 19, 2019 /PRNewswire/ — Concord Medical Services Holdings Limited (“Concord Medical” or the “Company”) (NYSE: CCM), a leading specialty hospital management solutions provider and an operator of the…
– License and Collaboration Agreement was signed between OliX and Théa for OLX301A program, a novel treatment for dry and wet age-related macular degeneration.– OliX to receive an upfront payment…
Multilingual WordPress with WPML